首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1684440

傷口護理生物製劑市場，按產品、按傷口類型、按最終用戶、按國家和地區 - 2025 年至 2032 年的行業分析、市場規模、市場佔有率和預測

Wound Care Biologics Market, By Product, By Wound Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2025年03月07日 | 出版商:

AnalystView Market Insights | 英文 379 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告重點

2024 年傷口護理生物製劑市場規模價值為 22.4565 億美元，2025 年至 2032 年期間複合年成長率為 5.5%。

傷口護理生物製劑市場-市場動態

壓瘡盛行率的不斷上升以及對生物製劑傷口治療的認知預計將推動市場需求

傷口護理生物製劑市場正在經歷顯著成長，推動因素有很多，包括慢性傷口的盛行率上升、生物技術的進步以及對生物製劑療法的認知。壓瘡和靜脈性腿部潰瘍的發生率增加，需要更有效的治療選擇，如生物工程皮膚替代品和羊膜組織產品，這也推動了市場成長。全球糖尿病病例的增加導致糖尿病足潰瘍的增加，需要生物製劑等先進的傷口癒合解決方案。根據國際糖尿病聯盟（IDF）的數據，全球約有 5.37 億成年人患有糖尿病，而且這一數字預計還會上升，導致對先進傷口護理的需求增加。

生物技術的快速進步促進了下一代傷口護理生物製劑的開發，可以加速癒合並減少併發症。人口老化是市場成長的關鍵因素，因為老年人更容易出現慢性傷口，因為壓瘡、組織再生等風險較高。包括美國在內的許多國家都根據醫療保險和醫療補助計劃為先進的傷口護理產品提供報銷，使得生物製劑更容易獲得。

傷口護理生物製劑市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 5.5%

根據產品細分，由於老年人對傷口癒合的需求很高，預計生物皮膚替代品領域將在 2024 年佔據最大的市場佔有率。

根據傷口類型細分，潰瘍細分市場是 2024 年領先的傷口類型細分市場，這是由於壓瘡和糖尿病足潰瘍等盛行率較高。

根據最終用戶細分，醫院部門是 2024 年領先的最終用戶部門，因為對傷口護理、外科護理等的需求很高。

從地區來看，北美將成為 2024 年的主要收入來源，這得益於糖尿病診斷方面先進的醫療保健解決方案。

傷口護理生物製劑市場-細分分析：

全球傷口護理生物製劑市場根據產品、傷口類型、最終用戶和地區進行細分。

根據產品，市場分為兩類：生物皮膚替代品和外用藥物。生物皮膚替代品領域佔據市場主導地位。從傳統治療轉變為生物製劑、生物工程組織的轉變日益加劇，推動了該領域的需求。

根據傷口類型，市場分為三類：潰瘍、手術和創傷傷口、燒傷。由於老年人中壓瘡發病率較高，預計潰瘍領域將佔據最大佔有率，從而促進該領域的成長。

根據最終用戶，市場分為三類：醫院、門診手術中心和其他。醫院部分佔據最終用戶部分的最高佔有率。對糖尿病、手術和燒傷治療的需求不斷成長，促進了市場的成長。

傷口護理生物製劑市場-地理洞察

在全球範圍內，傷口護理生物製劑市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。北美佔據傷口護理生物製劑市場的很大佔有率，這主要歸功於其先進的醫療保健基礎設施和慢性傷口的高盛行率。該地區人口老化和糖尿病發病率的上升增加了對先進傷口護理解決方案的需求。預計亞太地區將成為傷口護理生物製劑市場成長最快的地區。患者人數眾多、糖尿病等慢性病盛行率不斷上升以及醫療保健基礎設施不斷改善等因素推動了市場成長。拉丁美洲為傷口護理生物製劑提供了成長機會，其中巴西和墨西哥引領市場。

傷口護理生物製劑市場-競爭格局：

傷口護理生物製劑市場競爭激烈，主要參與者專注於研發，推出創新產品並擴大市場範圍。市場參與者專注於增強產品線，以滿足不斷成長的全球傷口護理市場的需求。生物技術的不斷創新帶來了更有效的傷口護理生物製劑，提高了治療效果。公司透過合作、合併和收購來擴大產品組合併加強市場佔有率。

市場片段
- 傷口護理生物製劑市場產品片段
- 傷口護理生物製劑市場片段（按傷口類型）
- 傷口護理生物製劑市場片段（按最終用戶）
- 傷口護理生物製劑市場片段（按國家/地區）
- 傷口護理生物製劑市場片段（按地區）
競爭洞察

第 3 章：傷口護理生物製劑主要市場趨勢

傷口護理生物製劑市場促進因素
- 市場促進因素的影響分析
傷口護理生物製劑市場限制
- 市場限制的影響分析
傷口護理生物製劑市場機會
傷口護理生物製劑市場未來趨勢

第 4 章：傷口護理生物製劑產業研究

PEST分析
波特五力分析
成長前景規劃
規範架構分析

第 5 章：傷口護理生物製劑市場：地緣政治緊張局勢升級的影響

新冠肺炎疫情的影響
俄烏戰爭的影響
中東衝突的影響

第 6 章：傷口護理生物製劑市場模式

傷口護理生物製劑市場佔有率分析，2024 年
按主要製造商分類的細分數據
- 成熟玩家分析
- 新興企業分析

第 7 章：傷口護理生物製劑市場 - 按產品

概述
- 按產品細分的佔有率分析
- 生物皮膚替代品
- 外用藥物

第 8 章：傷口護理生物製劑市場 - 依傷口類型

概述
- 按傷口類型分類的細分市場佔有率分析
- 潰瘍
- 手術與創傷傷口
- 燒傷

第 9 章：傷口護理生物製劑市場 - 按最終用戶

概述
- 按最終用戶細分的佔有率分析
- 醫院
- 門診手術中心
- 其他

第 10 章：傷口護理生物製劑市場 - 按地區分類

介紹
- 按地區分類的細分市場佔有率分析
北美洲
- 概述
- 北美傷口護理生物製劑主要製造商
- 北美市場規模及預測（按國家/地區）
- 北美市場規模及預測（按產品分類）
- 北美市場規模及預測（按傷口類型）
- 北美市場規模和預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲傷口護理生物製劑主要製造商
- 歐洲市場規模及預測（按國家）
- 歐洲市場規模及預測（依產品分類）
- 歐洲市場規模及預測（按傷口類型）
- 歐洲市場規模和預測（按最終用戶）
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 俄羅斯
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區傷口護理生物製劑主要製造商
- 亞太地區市場規模及預測（依國家/地區分類）
- 亞太地區市場規模及預測（依產品分類）
- 亞太地區市場規模及預測（依傷口類型）
- 亞太地區市場規模及預測（依最終用戶）
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 印尼
- 泰國
- 菲律賓
- 亞太地區其他地區
拉丁美洲 (LATAM)
- 概述
- 拉丁美洲傷口護理生物製劑主要製造商
- 拉丁美洲市場規模及預測（按國家/地區）
- 拉丁美洲市場規模及預測（按產品分類）
- 拉丁美洲市場規模及預測（按傷口類型）
- 拉丁美洲市場規模及預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 概述
- 中東和非洲傷口護理生物製劑主要製造商
- MEA 市場規模及預測（依國家/地區分類）
- MEA 市場規模及預測（依產品分類）
- MEA 市場規模及預測（依傷口類型）
- MEA 市場規模和預測（按最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 其他地區

第 11 章：主要供應商分析-傷口護理生物製劑產業

競爭儀錶板
- Competitive Benchmarking
- Competitive Positioning
公司簡介
- Smith & Nephew
- Molnlycke Health Care
- ConvaTec Group
- Coloplast
- 3M Health Care
- Organogenesis Holdings
- Integra LifeSciences
- MiMedx Group
- PolyNovo
- Derma Sciences
- Medline Industries
- Hollister Incorporated
- Aroa Biosurgery
- Kerecis
- Cresilon
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4871

REPORT HIGHLIGHT

Wound Care Biologics Market size was valued at USD 2,245.65 Million in 2024, expanding to a CAGR of 5.5% from 2025 to 2032.

Wound Care Biologics are advanced medical products derived from natural, biological sources that help facilitate wound healing. They are typically used in treating chronic wounds, burns, ulcers, and surgical wounds that are difficult to heal with conventional treatments.

Wound Care Biologics Market- Market Dynamics

Increasing prevalence of pressure ulcers and awareness about biologics based wound therapies are expected to propel market demand

The Wound Care Biologics Market is experiencing significant growth, driven by various factors, including the rising prevalence of chronic wounds, advancements in biotechnology and awareness about biologics therapies. The occurrence of pressure ulcers and venous leg ulcers has increased, necessitating more effective treatment options like bioengineered skin substitutes and amniotic tissue products which is also boosting market growth. The global increase in diabetes cases has led to a rise in diabetic foot ulcers, which require advanced wound healing solutions like biologics. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide have diabetes, and this number is expected to rise, leading to a higher demand for advanced wound care.

The rapid progress in biotechnology has led to the development of next-generation wound care biologics that accelerate healing and reduce complications. The aging population is a key contributor to market growth, as elderly individuals are more prone to chronic wounds due to high risks of pressure ulcers, tissue regeneration, etc. Governments and private entities are investing in biotechnology research to develop more effective and affordable wound care biologics. Many countries, including the U.S., provide reimbursement for advanced wound care products under Medicare and Medicaid programs, making biologics more accessible.

Wound Care Biologics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2025-2032)

Based on Product segmentation, the biological skin substitutes segment was predicted to show maximum market share in the year 2024, due to high demand from older aged adults for wound healing.

Based on Wound Type segmentation, the ulcers segment was the leading Wound Type segment in 2024, owing to the high prevalence of pressure ulcers and diabetic foot ulcers, etc.

Based on End User segmentation, the hospital segment was the leading End User segment in 2024, owing to the high need for wound care, surgical care, etc.

Based on the region, North America was the leading revenue generator in 2024, owing to the presence of advanced healthcare solutions in diabetic diagnosis.

Wound Care Biologics Market- Segmentation Analysis:

The Global Wound Care Biologics Market is segmented based on Product, Wound Type, End User, and Region.

The market is divided into two categories based on Product: biological skin substitutes and topical agents. The biological skin substitutes segment dominates the market. The growing shift from traditional treatment to biologics, bioengineered tissues is fueling segment demand.

The market is divided into three categories based on the Wound Type: ulcers, surgical & traumatic wounds, and burns. The ulcers segment is expected to hold the largest share due to the high prevalence of pressure ulcers among older adults is contributing to segment growth.

The market is divided into three categories based on End Users: hospitals, ambulatory surgical centers, and others. The hospitals segment holds the highest share of the End User segment. The growing demand for treatment of diabetes, surgeries & burns is supplementing market growth.

Wound Care Biologics Market- Geographical Insights

Across the world, the Wound Care Biologics market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the wound care biologics market, primarily due to its advanced healthcare infrastructure and high prevalence of chronic wounds. The region's aging population and increasing incidence of diabetes contribute to the demand for advanced wound care solutions. The Asia-Pacific region is anticipated to exhibit the fastest growth in the wound care biologics market. Factors such as a large patient population, increasing prevalence of chronic diseases like diabetes, and improving healthcare infrastructure drive market growth. Latin America offers growth opportunities in wound care biologics, with Brazil and Mexico leading the market.

Wound Care Biologics Market- Competitive Landscape:

The wound care biologics market is characterized by intense competition, with key players focusing on research and development to introduce innovative products and expand their market reach. Market players focusing on enhancing product lines to address the growing global wound care market. Continuous innovations in biotechnology have led to more effective wound care biologics, enhancing treatment outcomes. Companies engage in partnerships, mergers, and acquisitions to expand product portfolios and strengthen market presence.

Recent Developments:

In 2024, Cresilon developed Traumagel and algae derived gel which got FDA approval in August 2024.

In 2024, PolyNovo announced its plan to expand its manufacturing capabilities and enhance its product portfolio.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL WOUND CARE BIOLOGICS MARKET KEY PLAYERS

Smith & Nephew
Molnlycke Health Care
ConvaTec Group
Coloplast
3M Health Care
Organogenesis Holdings
Integra LifeSciences
MiMedx Group
PolyNovo
Derma Sciences
Medline Industries
Hollister Incorporated
Aroa Biosurgery
Kerecis
Cresilon
Others

GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

Biological Skin Substitutes
Topical Agents

GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE- MARKET ANALYSIS, 2019-2032

Ulcers
Surgical & Traumatic Wounds
Burns

GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Hospitals
Ambulatory Surgical Centers
Others
GLOBAL WOUND CARE BIOLOGICS MARKET BY REGION- MARKET ANALYSIS, 2019-2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Wound Care Biologics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Wound Care Biologics Market Snippet by Product
- 2.1.2. Wound Care Biologics Market Snippet by Wound Type
- 2.1.3. Wound Care Biologics Market Snippet by End User
- 2.1.4. Wound Care Biologics Market Snippet by Country
- 2.1.5. Wound Care Biologics Market Snippet by Region
2.2. Competitive Insights

3. Wound Care Biologics Key Market Trends

3.1. Wound Care Biologics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Wound Care Biologics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Wound Care Biologics Market Opportunities
3.4. Wound Care Biologics Market Future Trends

4. Wound Care Biologics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Wound Care Biologics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Wound Care Biologics Market Landscape

6.1. Wound Care Biologics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Wound Care Biologics Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Biological Skin Substitutes
- 7.1.3. Topical Agents

8. Wound Care Biologics Market - By Wound Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Wound Type, 2024 & 2032 (%)
- 8.1.2. Ulcers
- 8.1.3. Surgical & Traumatic Wounds
- 8.1.4. Burns

9. Wound Care Biologics Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Ambulatory Surgical Centers
- 9.1.4. Others

10. Wound Care Biologics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Wound Care Biologics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Wound Care Biologics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Wound Care Biologics Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Wound Care Biologics Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Wound Care Biologics Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Wound Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Wound Care Biologics Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Smith & Nephew
- 11.2.2. Molnlycke Health Care
- 11.2.3. ConvaTec Group
- 11.2.4. Coloplast
- 11.2.5. 3M Health Care
- 11.2.6. Organogenesis Holdings
- 11.2.7. Integra LifeSciences
- 11.2.8. MiMedx Group
- 11.2.9. PolyNovo
- 11.2.10. Derma Sciences
- 11.2.11. Medline Industries
- 11.2.12. Hollister Incorporated
- 11.2.13. Aroa Biosurgery
- 11.2.14. Kerecis
- 11.2.15. Cresilon
- 11.2.16. Others